Revive Therapeutics Statistics

Total Valuation

Revive Therapeutics has a market cap or net worth of CAD 2.09 million. The enterprise value is 1.10 million.

Market Cap	2.09M
Enterprise Value	1.10M

Important Dates

The last earnings date was Monday, September 16, 2024.

Earnings Date	Sep 16, 2024
Ex-Dividend Date	n/a

Share Statistics

Revive Therapeutics has 418.56 million shares outstanding. The number of shares has increased by 4.79% in one year.

Shares Outstanding	418.56M
Shares Change (YoY)	+4.79%
Shares Change (QoQ)	+8.55%
Owned by Insiders (%)	1.66%
Owned by Institutions (%)	0.01%
Float	411.61M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
PB Ratio	0.21
P/FCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-0.26
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 0.40, with a Debt / Equity ratio of 0.63.

Current Ratio	0.40
Quick Ratio	0.36
Debt / Equity	0.63
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-128.36

Financial Efficiency

Return on equity (ROE) is -39.01% and return on invested capital (ROIC) is -19.41%.

Return on Equity (ROE)	-39.01%
Return on Assets (ROA)	-14.75%
Return on Capital (ROIC)	-19.41%
Revenue Per Employee	n/a
Profits Per Employee	-2.11M
Employee Count	2
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -90.00% in the last 52 weeks. The beta is -0.19, so Revive Therapeutics's price volatility has been lower than the market average.

Beta (5Y)	-0.19
52-Week Price Change	-90.00%
50-Day Moving Average	0.01
200-Day Moving Average	0.02
Relative Strength Index (RSI)	38.90
Average Volume (20 Days)	626,151

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-3.41M
Pretax Income	-4.23M
Net Income	-4.23M
EBITDA	-3.41M
EBIT	-3.41M
Earnings Per Share (EPS)	-0.01

Full Income Statement

Balance Sheet

The company has 1.05 million in cash and 61,509 in debt, giving a net cash position of 987,886 or 0.00 per share.

Cash & Cash Equivalents	1.05M
Total Debt	61,509
Net Cash	987,886
Net Cash Per Share	0.00
Equity (Book Value)	9.82M
Book Value Per Share	0.02
Working Capital	-1.95M

Full Balance Sheet

Cash Flow

Operating Cash Flow	-3.58M
Capital Expenditures	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

Revive Therapeutics does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-4.79%
Shareholder Yield	-4.79%
Earnings Yield	-237.42%
FCF Yield	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	n/a